The grants have been the source of new treatments for cancer, heart disease, diabetes, strokes and H.I.V.; wonder drugs like ...
A quirk in the website OpenSecrets has given RFK Jr. a chance to misleadingly portray Sen. Bernie Sanders as receiving big ...
U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...
When done safely and securely, automated inbound engagement can provide significant benefits for pharmaceutical companies.
Sudair Pharma aims to localise insulin production, contributing to the continuity of supply and reducing reliance on imports ...
The Trump administration's decision to pause enforcement of an anti-bribery law raised the specter that drugmakers could ...
Pharmaceutical manufacturers may need new models to maintain sustainable businesses and support patients who cannot afford ...
Vaccine policy, Medicare drug negotiations, and a potential DTC advertising ban will all fall under Kennedy’s purview as HHS ...
Top Republican recipients of contributions from employees or PACS associated with the pharmaceutical/health products ...
Now that the year is underway and a new presidential administration is in place in Washington, let’s consider the environment ...
Health and Human Services Secretary Robert F. Kennedy Jr. said any staffers in the department who are “working for the ...
U.S. investors and pharmaceutical giants are increasingly looking to China for drug innovation, with nearly 30% of major pharma deals last year involving Chinese companies—up from 0% in 2019.